Rescue of Epstein-Barr virus from somatic cell hybrids of Burkitt lymphoblastoid cells.
A Burkitt lymphoblastoid cell line, P3J-HR-1, was fused and hybridized to a human sternal marrow cell line. The somatic cell hybrids were negative when examined for Epstein-Barr virus (EBV) markers. When the hybrid cells were exposed to 5-iododeoxyuridine, both EBV-specific antigens and virus particles were induced as determined by the immunofluorescence test and by electron microscopy. The data presented suggest that the EBV genome can be transferred from a lymphoblastoid cell to another cell type during cell hybridization, that the EBV genome can persist in the hybrid cells for long periods of time, and that synthesis of the virus can be induced in the heterokaryons.
D000956:Antigens, Viral / Q000302:isolation & purification; D002051:Burkitt Lymphoma; D002459:Cell Fusion; D002460:Cell Line / Q000382:microbiology; D002467:Cell Nucleus / Q000276:immunology; D003470:Culture Media; D003593:Cytoplasm / Q000276:immunology; D005455:Fluorescent Antibody Technique; D004854:Herpesvirus 4, Human / Q000254:growth & development / Q000276:immunology / Q000302:isolation & purification*; D006801:Humans; D006822:Hybrid Cells / Q000166:cytology / Q000187:drug effects / Q000276:immunology / Q000382:microbiology*; D007042:Hypoxanthines; D007065:Idoxuridine / Q000494:pharmacology; D008854:Microscopy, Electron; D010222:Parainfluenza Virus 1, Human / Q000254:growth & development
D000956:Antigens, Viral; D003470:Culture Media; D007042:Hypoxanthines; D007065:Idoxuridine